Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
E: [email protected]
Dr Richardson is a pharmacist, with a Ph.D. in pharmaceutics from The Queens University, Belfast. He worked for a number of years in the pharmaceutical industry (1991-1998) in the UK and Italy in the area of formulation research and development, with companies such as Bristol-Myers Squibb, SmithKline Beecham, Pfizer and Serono, concentrated mainly on drug delivery and controlled release systems for small and large molecules. He has worked for the UK MHRA as a pharmaceutical assessor (1998-2004), with time assessing chemical and abridged applications and wide ranging experience of biotechnology / biological applications. He was UK delegate for the CHMP Biologics Working Party prior to joining the European Medicines Agency, where he had roles of scientific administrator (2004-2010) and Head of Biologicals Section (2010-2013). He was Head of Quality Office (2013 – 2021), managing the oversight of the many aspects relating to quality of chemical and biological medicinal products. Since 2021 he has continued to support, as scientific secretary, the Biologics and currently, the Biosimilar Working Party at the European Medicines Agency.